NO20025964D0 - Ny interferon for behandling av multippel sklerose - Google Patents
Ny interferon for behandling av multippel skleroseInfo
- Publication number
- NO20025964D0 NO20025964D0 NO20025964A NO20025964A NO20025964D0 NO 20025964 D0 NO20025964 D0 NO 20025964D0 NO 20025964 A NO20025964 A NO 20025964A NO 20025964 A NO20025964 A NO 20025964A NO 20025964 D0 NO20025964 D0 NO 20025964D0
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- multiple sclerosis
- new interferon
- interferon
- new
- Prior art date
Links
- 102000014150 Interferons Human genes 0.000 title 1
- 108010050904 Interferons Proteins 0.000 title 1
- 229940079322 interferon Drugs 0.000 title 1
- 201000006417 multiple sclerosis Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21204600P | 2000-06-16 | 2000-06-16 | |
US09/881,050 US20020025304A1 (en) | 2000-06-16 | 2001-06-15 | Novel interferon for the treatment of multiple sclerosis |
PCT/US2001/041022 WO2001095929A2 (en) | 2000-06-16 | 2001-06-18 | Interferon for treatment of multiple sclerosis |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20025964D0 true NO20025964D0 (no) | 2002-12-12 |
NO20025964L NO20025964L (no) | 2003-02-14 |
Family
ID=26906704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20025964A NO20025964L (no) | 2000-06-16 | 2002-12-12 | Ny interferon for behandling av multippel sklerose |
Country Status (22)
Country | Link |
---|---|
US (1) | US20020025304A1 (no) |
EP (1) | EP1289541A2 (no) |
JP (1) | JP2004505021A (no) |
KR (1) | KR20030009529A (no) |
CN (1) | CN1436086A (no) |
AU (1) | AU2001267099A1 (no) |
BG (1) | BG107370A (no) |
BR (1) | BR0111852A (no) |
CA (1) | CA2413077A1 (no) |
CZ (1) | CZ20024094A3 (no) |
EE (1) | EE200200693A (no) |
HU (1) | HUP0300787A2 (no) |
IL (1) | IL152996A0 (no) |
LT (1) | LT2002123A (no) |
MX (1) | MXPA02012308A (no) |
NO (1) | NO20025964L (no) |
NZ (1) | NZ522849A (no) |
PL (1) | PL359562A1 (no) |
RU (1) | RU2003100517A (no) |
SI (1) | SI21080A (no) |
SK (1) | SK17612002A3 (no) |
WO (1) | WO2001095929A2 (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7314613B2 (en) * | 2002-11-18 | 2008-01-01 | Maxygen, Inc. | Interferon-alpha polypeptides and conjugates |
NZ540043A (en) * | 2002-11-18 | 2007-11-30 | Maxygen Inc | Isolated or recombinant Interferon-alpha polypeptides and conjugates |
EP1712992A1 (en) * | 2005-04-11 | 2006-10-18 | Sony Ericsson Mobile Communications AB | Updating of data instructions |
US8895700B2 (en) | 2010-02-18 | 2014-11-25 | Janssen Biotech, Inc. | Monkey homolog of human interferon omega |
EP3411065B1 (en) | 2016-02-05 | 2021-03-31 | Orionis Biosciences BV | Clec9a binding agents |
CA3052523A1 (en) | 2017-02-06 | 2018-08-09 | Orionis Biosciences Nv | Targeted chimeric proteins and uses thereof |
JP2020505955A (ja) | 2017-02-06 | 2020-02-27 | オリオンズ バイオサイエンス インコーポレイテッド | 標的化改変型インターフェロン及びその使用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6372206B1 (en) * | 1989-03-02 | 2002-04-16 | University Of Florida | Orally-administered interferon-TAU compositions and methods |
SI9520059A (en) * | 1994-05-10 | 1997-08-31 | Immulogic Pharma Corp | Compositions and treatment for multiple sclerosis. |
US6299869B1 (en) * | 1997-12-08 | 2001-10-09 | Genentech, Inc. | Human interferon-epsilon: a type I interferon |
IL139933A0 (en) * | 1998-05-29 | 2002-02-10 | Biogen Inc | A liquid composition containing recombinant interferon-beta |
EP1141296A2 (en) * | 1998-09-18 | 2001-10-10 | ZymoGenetics, Inc. | Interferon-epsilon |
US20030175897A1 (en) * | 2000-04-14 | 2003-09-18 | Thayer Edward C. | Human interferon, Zinf2 |
-
2001
- 2001-06-15 US US09/881,050 patent/US20020025304A1/en not_active Abandoned
- 2001-06-18 PL PL01359562A patent/PL359562A1/xx not_active Application Discontinuation
- 2001-06-18 IL IL15299601A patent/IL152996A0/xx unknown
- 2001-06-18 AU AU2001267099A patent/AU2001267099A1/en not_active Abandoned
- 2001-06-18 JP JP2002510107A patent/JP2004505021A/ja active Pending
- 2001-06-18 EE EEP200200693A patent/EE200200693A/xx unknown
- 2001-06-18 NZ NZ522849A patent/NZ522849A/en unknown
- 2001-06-18 MX MXPA02012308A patent/MXPA02012308A/es unknown
- 2001-06-18 EP EP01944716A patent/EP1289541A2/en not_active Withdrawn
- 2001-06-18 WO PCT/US2001/041022 patent/WO2001095929A2/en not_active Application Discontinuation
- 2001-06-18 BR BR0111852-8A patent/BR0111852A/pt not_active Application Discontinuation
- 2001-06-18 CA CA002413077A patent/CA2413077A1/en not_active Abandoned
- 2001-06-18 RU RU2003100517/15A patent/RU2003100517A/ru not_active Application Discontinuation
- 2001-06-18 CN CN01811184A patent/CN1436086A/zh active Pending
- 2001-06-18 CZ CZ20024094A patent/CZ20024094A3/cs unknown
- 2001-06-18 KR KR1020027017090A patent/KR20030009529A/ko not_active Application Discontinuation
- 2001-06-18 SI SI200120032A patent/SI21080A/sl not_active IP Right Cessation
- 2001-06-18 HU HU0300787A patent/HUP0300787A2/hu unknown
- 2001-06-18 SK SK1761-2002A patent/SK17612002A3/sk unknown
-
2002
- 2002-12-02 LT LT2002123A patent/LT2002123A/xx unknown
- 2002-12-11 BG BG107370A patent/BG107370A/xx unknown
- 2002-12-12 NO NO20025964A patent/NO20025964L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2001267099A1 (en) | 2001-12-24 |
EE200200693A (et) | 2004-06-15 |
US20020025304A1 (en) | 2002-02-28 |
JP2004505021A (ja) | 2004-02-19 |
SK17612002A3 (sk) | 2003-08-05 |
HUP0300787A2 (hu) | 2003-07-28 |
RU2003100517A (ru) | 2004-06-27 |
WO2001095929A3 (en) | 2002-10-10 |
SI21080A (sl) | 2003-06-30 |
CZ20024094A3 (cs) | 2003-05-14 |
MXPA02012308A (es) | 2003-04-25 |
PL359562A1 (en) | 2004-08-23 |
KR20030009529A (ko) | 2003-01-29 |
NZ522849A (en) | 2004-05-28 |
WO2001095929A2 (en) | 2001-12-20 |
CA2413077A1 (en) | 2001-12-20 |
IL152996A0 (en) | 2003-06-24 |
CN1436086A (zh) | 2003-08-13 |
NO20025964L (no) | 2003-02-14 |
EP1289541A2 (en) | 2003-03-12 |
BG107370A (en) | 2003-11-28 |
BR0111852A (pt) | 2003-05-20 |
LT2002123A (en) | 2003-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60136181D1 (de) | 3'-prodrugs von 2'-deoxy-beta-l-nukleosiden | |
DE50206657D1 (de) | Pharmazeutische zusammensetzung zur behandlung von multiple sklerose | |
IT1318649B1 (it) | Composizioni farmaceutiche per il trattamento di mucositi e stomatiti. | |
DE60132600D1 (de) | Medikamente zur chemotherapeutischen behandlung von erkrankungen | |
EE05020B1 (et) | Glburiidi ravimkoostis | |
NO20040253L (no) | Fremgangsmater for behandling av leverfibroser | |
DE60126814D1 (de) | Inhalation von stickoxid | |
DE50209245D1 (de) | Neuroprotektives medikament | |
NO20034123L (no) | Fremgangsmåte for behandling av brennstoff | |
NO20041968L (no) | Anvendelse av cystationin | |
NO20031525L (no) | Kjemokinmutanter i behandlingen av multippel sklerose | |
NO20013337L (no) | Ny behandling | |
NO20025964L (no) | Ny interferon for behandling av multippel sklerose | |
FR2791258B1 (fr) | Composition amincissante | |
NO20032769L (no) | Kombinasjonsmetode for behandling av virale infeksjoner | |
NO20042476L (no) | Anvendelse av desoxypeganin for behandling av klinisk depresjon | |
DE60007360D1 (de) | Amorphe modifikation von torasemid | |
NO20030515D0 (no) | Fremgangsmåte for fremstilling av dinapsolin | |
GB0114231D0 (en) | Treatment of multiple sclerosis | |
NO20014845D0 (no) | Anvendelse av arylalkanoylpyridaziner | |
DE60207900D1 (de) | "Suspend"-Paketübertrager | |
ITMI20011820A0 (it) | Trattamento di ustioni | |
AU2002366793A1 (en) | Improved lilly of the valley aromachemicals | |
NO20025765L (no) | Kombinasjonssett for behandling av malaria | |
NO20023702D0 (no) | Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |